BlackRock Group’s Alder Biopharmaceuticals ALDR Stock Holding History

BlackRock Group’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.08M	Sell	52,128 -13,501	-21%	-$351K	﹤0.01%	2101
2016 Q3	$2.15M	Buy	65,629 +6,916	+12%	+$211K	﹤0.01%	1573
2016 Q2	$1.47M	Sell	58,713 -11,783	-17%	-$319K	﹤0.01%	1751
2016 Q1	$1.73M	Sell	70,496 -224,882	-76%	-$5.21M	﹤0.01%	1633
2015 Q4	$9.76M	Sell	295,378 -4,523	-2%	-$153K	0.01%	927
2015 Q3	$9.82M	Sell	299,901 -37,023	-11%	-$1.57M	0.01%	928
2015 Q2	$17.8M	Buy	336,924 +17,126	+5%	+$623K	0.01%	835
2015 Q1	$9.23M	Buy	319,798 +175,098	+121%	+$4.8M	0.01%	980
2014 Q4	$4.21M	Sell	144,700 -6,386	-4%	-$115K	﹤0.01%	1174
2014 Q3	$1.92M	Sell	151,086 -18,745	-11%	-$283K	﹤0.01%	1435
2014 Q2	$3.41M	Buy	+169,831	New	+$2.39M	﹤0.01%	1255

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Group's ALDR Position: Q4 2016 in Review

BlackRock Group reduced its Alder Biopharmaceuticals (ALDR) stake by 21% in Q4 2016, selling an estimated $351K and leaving 52,128 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2101.

BlackRock Group first reported a position in ALDR in Q2 2014 and has held it in 11 quarters since. The position peaked at $17.8M in Q2 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

BlackRock Group held 52,128 shares of Alder Biopharmaceuticals worth $1.08M as of Q4 2016.
BlackRock Group sold 13,501 Alder Biopharmaceuticals shares in Q4 2016, an estimated $351K.
Alder Biopharmaceuticals made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2101 holding.
BlackRock Group first reported a position in Alder Biopharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Group's Alder Biopharmaceuticals position peaked at $17.8M in Q2 2015.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.